New math formula could make lithium blood tests more flexible for bipolar patients

NCT ID NCT07306039

Ongoing Knowledge-focused Sponsor: Ole Köhler-Forsberg Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new method called eLi12 that estimates lithium levels in the blood even when the blood test isn't taken exactly 12 hours after the last dose. Researchers want to see if 200 people with bipolar disorder can reliably record when they took their lithium, and whether eLi12 gives more consistent results than standard tests. The goal is to make lithium monitoring more convenient for patients and clinicians.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER (BD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIPOLAR DISORDER (BD)

Contacts and locations

Show contact details

Locations

Clinic for Bipolar Disorder, Aarhus University Hospital Psychiatry

Aarhus, Denmark
Psychiatric Hospital Gødstrup

Herning, Denmark
Psychiatric Hospital Randers

Randers, Denmark